Individuals with higher blood lead levels experienced greater decreases in eGFR.
Low-level exposure to lead is associated with decreased kidney function, accordingto a recent study published online ahead of print in the American Journalof Kidney Diseases.
In a prospective population-based cohort, Florencia Harari, MD, PhD, ofSahlrenska University Hospital and University of Gothenburg, Sweden, and colleaguesfound that individuals with blood lead levels in quartiles 3 and 4 (median29 and 46 μg/L, respectively) experienced significantly greater decreases in estimatedglomerular filtration rate from baseline to follow-up (about 16 years later)than those with blood levels in quartile 1 (median 15 μg/L).
In a model adjusted for age, sex, smoking alcohol intake, and other potentialconfounders, individuals in the quartile 4 had a significant 49% increased risk ofchronic kidney disease compared with those in the quartiles 1–3 (reference), theinvestigators reported.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.